Legal & General Group PLC Crinetics Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$423 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 63,952 shares of CRNX stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,952

Previous 63,952 -0.0%

Holding current value

$2.86 Million

Previous $2.99 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$34.76 - $46.81 $342,281 - $460,938	9,847 Added 18.2%	63,952 $2.99 Million
Q4 2023 Feb 15, 2024	BUY	$25.62 - $37.07 $12,861 - $18,609	502 Added 0.94%	54,105 $1.93 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $251,607 - $481,945	15,755 Added 41.63%	53,603 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $240,684 - $361,103	15,301 Added 67.86%	37,848 $682,000
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $101,061 - $139,281	6,601 Added 41.4%	22,547 $362,000

Q4 2022 Feb 14, 2023	BUY	$15.49 - $19.05 $10,610 - $13,049	685 Added 4.49%	15,946 $291,000
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $15,049 - $18,589	831 Added 5.76%	15,261 $300,000
Q2 2022 Aug 22, 2022	BUY	$16.49 - $27.64 $3,116 - $5,223	189 Added 1.33%	14,430 $269,000
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $6,688 - $11,040	390 Added 2.82%	14,241 $313,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $82,721 - $121,452	4,275 Added 44.64%	13,851 $393,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $75,673 - $113,106	4,483 Added 88.02%	9,576 $202,000
Q2 2021 Aug 12, 2021	BUY	$15.9 - $21.15 $13,642 - $18,146	858 Added 20.26%	5,093 $96,000
Q1 2021 May 17, 2021	BUY	$13.3 - $17.55 $3,059 - $4,036	230 Added 5.74%	4,235 $64,000
Q3 2020 Nov 13, 2020	SELL	$13.62 - $17.66 $15,308 - $19,849	-1,124 Reduced 21.91%	4,005 $63,000
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $42,471 - $75,660	3,257 Added 173.99%	5,129 $90,000
Q1 2020 May 14, 2020	SELL	$11.52 - $26.46 $4,492 - $10,319	-390 Reduced 17.24%	1,872 $28,000
Q4 2019 Feb 13, 2020	BUY	$15.24 - $25.09 $6,385 - $10,512	419 Added 22.73%	2,262 $54,000
Q2 2019 Aug 14, 2019	BUY	$21.48 - $27.71 $8,162 - $10,529	380 Added 25.97%	1,843 $46,000
Q1 2019 May 15, 2019	BUY	$21.07 - $29.31 $8,638 - $12,017	410 Added 38.94%	1,463 $33,000
Q3 2018 Nov 20, 2018	BUY	$22.66 - $36.8 $23,860 - $38,750	1,053 New	1,053 $30,000

Others Institutions Holding CRNX

# of Institutions

220

Shares Held

75.8M

Call Options Held

631K

Put Options Held

749K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.41B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Crinetics Pharmaceuticals, Inc. Transaction History